Literature DB >> 14648415

Tolerance and efficacy of argon plasma coagulation for controlling bleeding in patients with typical and atypical manifestations of watermelon stomach.

S Roman1, J C Saurin, J Dumortier, A Perreira, G Bernard, T Ponchon.   

Abstract

BACKGROUND AND STUDY AIMS: Watermelon stomach is a well-known cause of gastrointestinal bleeding and anemia. This study investigated the efficacy of and patient tolerance for argon plasma coagulation (APC) in this condition. PATIENTS AND METHODS: The reports of 21 patients with watermelon stomach who were treated using APC from February 1998 to August 2001 were reviewed. The efficacy of APC was evaluated on the basis of the patients' symptoms, transfusion requirements, and hemoglobin levels.
RESULTS: Fifty-nine APC sessions were carried out (mean 2.81 sessions per patient, range one to five). Depending on the bleeding outcome and lesion intensity, repeat treatments were carried out with a mean delay of 1.8 months (range 2 days - 6 months). The mean follow-up period after the last session was 14.9 months (1 - 60.6 months). All of the patients required repeated blood transfusions before APC, compared with only two patients after treatment. One of these two patients died of uncontrolled bleeding despite APC. The mean hemoglobin level was 80.9 g/l before treatment, compared with 103.2 g/l after treatment. Three patients had recurrent bleeding 4.4 - 31.7 months (mean 13.8 months) after the last session and required a further session of APC, which controlled bleeding in all cases. Complications encountered consisted of two cases of hematemesis and one of sepsis.
CONCLUSIONS: APC was effective in controlling bleeding due to watermelon stomach in the great majority of patients, with a low complication rate.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14648415     DOI: 10.1055/s-2003-44594

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  23 in total

Review 1.  The Role of Therapeutic Endoscopy in Patients With Cirrhosis-Related Causes of Gastrointestinal Bleeding.

Authors:  Camille A Kezer; Neil Gupta
Journal:  Curr Gastroenterol Rep       Date:  2018-06-09

Review 2.  Management of gastropathy and gastric vascular ectasia in portal hypertension.

Authors:  Cristina Ripoll; Guadalupe Garcia-Tsao
Journal:  Clin Liver Dis       Date:  2010-05       Impact factor: 6.126

Review 3.  Endoscopic Treatment for Gastric Antral Vascular Ectasia: Current Options.

Authors:  Sergio Zepeda-Gómez
Journal:  GE Port J Gastroenterol       Date:  2016-12-21

4.  Radiofrequency ablation for patients with refractory symptomatic anaemia secondary to gastric antral vascular ectasia.

Authors:  Cormac Magee; Gideon Lipman; Durayd Alzoubaidi; Martin Everson; Rami Sweis; Matthew Banks; David Graham; Charles Gordon; Laurence Lovat; Charles Murray; Rehan Haidry
Journal:  United European Gastroenterol J       Date:  2018-11-15       Impact factor: 4.623

5.  Endoscopic band ligation for refractory gastric antral vascular ectasia associated with liver cirrhosis.

Authors:  Takahiro Sato; Katsu Yamazaki; Jun Akaike; Takumi Ohmura; Yoshiyasu Karino; Jouji Toyota
Journal:  Clin J Gastroenterol       Date:  2011-01-13

Review 6.  Role of endoscopy in management of gastrointestinal complications of portal hypertension.

Authors:  Carmelo Luigiano; Giuseppe Iabichino; Antonino Judica; Clara Virgilio; Valentina Peta; Ludovico Abenavoli
Journal:  World J Gastrointest Endosc       Date:  2015-01-16

7.  Treatment of watermelon stomach.

Authors:  Gareth S Dulai; Dennis M Jensen
Journal:  Curr Treat Options Gastroenterol       Date:  2006-04

8.  Diagnosis and management of gastric antral vascular ectasia.

Authors:  Lorenzo Fuccio; Alessandro Mussetto; Liboria Laterza; Leonardo Henry Eusebi; Franco Bazzoli
Journal:  World J Gastrointest Endosc       Date:  2013-01-16

Review 9.  Portal hypertension and gastrointestinal bleeding: diagnosis, prevention and management.

Authors:  Erwin Biecker
Journal:  World J Gastroenterol       Date:  2013-08-21       Impact factor: 5.742

10.  Treatment of gastropathy and gastric antral vascular ectasia in patients with portal hypertension.

Authors:  Cristina Ripoll; Guadalupe Garcia-Tsao
Journal:  Curr Treat Options Gastroenterol       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.